Background: Vitamin D may play a pivotal role in regulating insulin secretion and insulin sensitivity. However, the effect of vitamin D intake, either from the diet or from supplements, on the development of gestational diabetes mellitus (GDM) remains unclear. We prospectively examined the association of prepregnancy habitual intake of vitamin D from diet and supplements with the risk of incident GDM in a well-established cohort. Methods: The present study was performed on 21 356 singleton pregnancies from 15 225 women in the Nurses' Health Study II cohort. Diet information, including vitamin D intake from food sources and supplements, was assessed in 1991 and every 4 years thereafter by validated food frequency questionnaires. Log-binomial models with generalized estimating equations were used to estimate relative risks (RRs) and 95% confidence intervals (CIs). Results: During 10 years of follow-up, 865 incident GDM cases were documented. After adjustment for age, parity, race/ethnicity, family history of diabetes, dietary and lifestyle factors, and body mass index, the RRs (95% CIs) of GDM risk associated with supplemental vitamin D intake of 0, 1-399, and ≥400 IU/day were 1.00 (reference), 0.80 (0.67-0.96), and 0.71 (0.56-0.90), respectively (P trend = 0.002). Dietary and total vitamin D intakes were also inversely associated with GDM risk, but the associations were not statistically significant.
Introduction
Gestational diabetes mellitus (GDM), characterized by glucose intolerance with onset or first recognition during pregnancy, is a common pregnancy complication that affects approximately 9% of all pregnancies. 1 Gestational diabetes mellitus is not only associated with adverse pregnancy and perinatal outcomes, but also related to an increased risk of long-term adverse health outcomes for both mother and child in later life, including type 2 diabetes mellitus (T2DM), metabolic syndrome, and cardiovascular disease. 2 For example, women with a history of GDM have a more than sevenfold increased risk of developing T2DM. 3 Thus, it is crucial to identify important modifiable risk factors that could prevent the development of GDM.
Vitamin D insufficiency is widespread around the world across various age groups. 4 In the US, the prevalence of vitamin D insufficiency, defined as 25-hydroxyvitamin D (25(OH)D) concentrations <75 nmol/L, is 83% among pregnant women in the first trimester. 5 Moreover, 78% of non-pregnant women of childbearing age have vitamin D insufficiency. 5 These data indicate that a substantial number of women may enter pregnancy with suboptimal vitamin D status.
Evidence from previous studies in animals and humans suggests that vitamin D may play a pivotal role in regulating insulin secretion [6] [7] [8] and insulin sensitivity. 6, 9 In addition, improved vitamin D status by vitamin D supplementation could normalize fasting glucose levels and attenuate insulin resistance in pregnant women. [10] [11] [12] Some, although not all, previous studies found that maternal low concentrations of 25(OH)D during early pregnancy were associated with increased risk of GDM. 13, 14 Interestingly, a recent animal study has shown that high vitamin D status before pregnancy, but not during pregnancy, is inversely associated with the development of GDM. 15 However, the effect of vitamin D intake, either from the diet or from supplements, on the development of GDM has not been investigated. Using data from a well-established prospective cohort, in the present study we examined the association between prepregnancy vitamin D intake and risk of GDM.
Methods

Study population
The Nurses' Health Study II (NHSII) is a prospective cohort study established in 1989, with 116 430 female nurses aged 24-44 years at study inception (see https:// www.nhs3.org/index.php/our-story/20-nurses-health-study -2, accessed 16 October 2017). The participants reported information regarding disease outcomes and lifestyle behaviors, such as smoking status and medication use, on a biennial questionnaire. Follow-up for each questionnaire cycle was >90%. The NHSII was approved by the Partners Human Research Committee (Boston, MA, USA), with participants' consent implied by the return of the questionnaires by mail.
Participants of NHSII were included in the present analysis if they had at least one singleton pregnancy lasting longer than 6 months between 1991 and 2001. The 2001 questionnaire was the last time questions regarding GDM were included, because the majority of NHSII participants had passed reproductive age by then. Pregnancies became eligible if there was no prior GDM or a prior diagnosis of T2DM, cardiovascular disease, or cancer. We excluded individuals who had missing information on vitamin D intake at baseline. Women with GDM in a previous pregnancy were not included because they may change their diet and lifestyle during the next pregnancy to prevent recurrent GDM.
Exposure assessment
Intakes of dietary vitamin D, other nutrients, and alcohol were assessed in 1991 and every 4 years thereafter using an extensively validated food frequency questionnaire (FFQ). [16] [17] [18] [19] Information on current use and doses of specific vitamin D supplements and vitamin Dcontaining multivitamins was collected biennially. Total vitamin D intake was calculated as the sum of dietary and supplemental vitamin D intakes from all sources.
Covariate assessment
Data on age, race/ethnicity, residence, anthropometric measures, physical activity, and dietary intake were collected using standardized questionnaires. Height and weight were reported in 1989 and weight was updated every 2 years. Self-reported body weight was highly correlated (r = 0.97) with technician-measured weight in a previous validation study. 20 Body mass index (BMI) was computed as weight in kilograms divided by height in meters squared. Physical activity was assessed by frequency of engaging in common recreational activities in 1991 and 1997. Total physical activity was calculated as metabolic equivalent task (MET) hours per week. In a previous validation study, the questionnaire-based estimates of physical activity correlated well (r = 0.56) with detailed activity diaries. 21 We calculated the Alternate Healthy Eating Index 2010 (AHEI), as described previously, 22 to represent overall diet quality. Previous studies have linked higher AHEI scores, indicating a better diet quality, to a lower risk of major chronic diseases. 22 Race/ethnicity (Caucasians, African American, Hispanic, Asian, others) was reported in 1989. In addition to dietary and supplemental vitamin D intake, solar ultraviolet B (UVB) radiation is considered a key source of circulating 25(OH)D, because UVB stimulates the conversion from 7-dehydrocholesterol to vitamin D 3 in the epidermis of the skin. Average annual UVB flux, a composite measure of mean UVB radiation level on the Earth's surface taking into account factors such as latitude, altitude, and cloud cover, was approximated based on state of residence (i.e. mailing address) on each of the questionnaires. 23 
Outcome ascertainment
On each of the biennial questionnaires from 1991 to 2001, the NHSII participants reported incident GDM as diagnosed by a physician. In the case of more than one pregnancy lasting longer than 6 months reported within a 2-year questionnaire period, GDM status was attributed to the first pregnancy. Self-reports on GDM diagnosis have previously been validated among a subgroup of the NHSII cohort, with 94% of GDM selfreports confirmed by medical records. 24 In a random sample of parous women without GDM, a high level of GDM surveillance was observed, with 83% reporting a glucose screening test during pregnancy and 100% reporting frequent prenatal urine screenings during pregnancy. 24 During the period that GDM events were reported in the present study (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) (2001) , the National Diabetes Data Group criteria 25 have been widely adopted for GDM diagnosis.
Statistical analysis
Log-binomial models 26 with generalized estimating equations (GEE) were used to estimate relative risks (RRs) and 95% confidence intervals (CIs). The GEE method allows us to account for correlations among repeated observations (pregnancies) contributed by a single participant. 27 The updated cumulative average vitamin D intake for each individual was calculated at each time period in order to represent long-term usual vitamin D intake and reduce within-subject variation. 28 For vitamin D intake, we fit multivariable models adjusting for age, parity, race/ethnicity, family history of diabetes, cigarette smoking, alcohol intake, physical activity, estimated UVB flux, BMI, total energy intake, and intakes of saturated fat, monounsaturated fatty acids, polyunsaturated fatty acids, transunsaturated fatty acids, dietary cholesterol, glycemic load, dietary fiber, magnesium, calcium, and vitamin A. All these variables were updated throughout the follow-up, except family history of diabetes and race/ethnicity, which were reported in 1989. To test for a significant trend across quartiles, we modeled median values of each category as a continuous variable.
To evaluate effect modification, we conducted stratified analyses according to age (<35 vs ≥35 years), family history of diabetes (yes vs no), overall diet quality (AHEI dietary pattern score < median vs AHEI dietary pattern score ≥ median), physical activity (<median vs ≥ median), and overweight status (BMI <25 vs ≥25 kg/m 2 ). Potential interactions were tested by adding multiplicative interaction terms in the multivariable models. All statistical analyses were performed using SAS version 9.2 (SAS Institute, Cary, NC, USA). Twosided P < 0.05 was considered significant.
Results
During 10 years of follow-up, 865 incident GDM pregnancies were documented among 21 356 eligible singleton pregnancies from 15 225 women. At baseline in 1991, women with higher total vitamin D intake were more likely to be White and non-smokers, more physically active, consumed more carbohydrates, protein, dietary fiber, magnesium, potassium, calcium, vitamin A, vitamin C, vitamin E, fish, low-fat dairy, nuts, fruits, and whole grains, less alcohol, fat, red meat, and sugarsweetened beverages, and had an overall better diet quality (Table 1) .
We observed a significant inverse association between supplemental vitamin D intake and the risk of GDM (Table 2) . After adjustment for age, parity, non-dietary factors, and dietary factors including dietary vitamin D intake, the adjusted RRs (95% CIs) of GDM risk associated with supplemental vitamin D intake of 0, 1-399, and ≥400 IU/day were 1.00 (reference), 0.80 (0.67-0.96), and 0.71 (0.56-0.90), respectively (P trend = 0.002).
Dietary and total vitamin D intakes were also inversely associated with GDM risk, but the associations were not statistically significant. The associations of total, dietary, and supplemental vitamin D intake with risk of GDM were not significantly modified by other risk factors for GDM, including age, family history of diabetes, overall diet quality, physical activity, or overweight status.
Discussion
In the present large prospective cohort study, we found inverse associations of prepregnancy supplemental vitamin D intake with the risk of GDM. These associations remained statistically significant after adjustment for other major risk factors of GDM. Our results also suggested that dietary and total vitamin D intakes may be Unless specified otherwise, data are given as the mean (SD). All comparisons were significant across categories, except family history of diabetes and body mass index (BMI). %E, % of energy; AHEI, Alternate Healthy Eating Index; 22 MET, metabolic equivalent; SSBs, sugar-sweetened beverages; UVB, ultraviolet B.
*Value is energy adjusted.
inversely associated with GDM risk, although the associations were not statistically significant. To our knowledge, the present study is the first attempt to examine the association between prepregnancy vitamin D intake and GDM risk. Accumulating evidence suggests that most women with GDM may have a chronic β-cell defect and insulin resistance before pregnancy. 29 Pregnancy itself is a process of progressive insulin resistance that begins near mid-pregnancy. The metabolic challenges occurring during pregnancy 29 serve to unmask a predisposition to glucose metabolic disorders in women who have a pre-existing compromised capacity to compensate for the progressive insulin resistance of pregnancy. 29 Therefore, prepregnancy risk factors implicated in glucose homeostasis may also be physiologically relevant to the development of GDM. In a previous study in female guinea pigs, high vitamin D status before pregnancy was inversely associated with the development of GDM. 15 The results of the present study were generally consistent with previous cohort studies relating dietary and supplemental vitamin D intake to T2DM risk. 30, 31 Moreover, we concur with previous findings showing the effects vitamin D supplementation on improved glucose metabolism and insulin sensitivity in pregnant women. [10] [11] [12] Several epidemiological studies examining the association between maternal circulating vitamin D levels during pregnancy and the risk of GDM have yielded equivocal results. 32, 33 In line with our findings on the association between vitamin D intake and GDM risk, a meta-analysis of previous studies has demonstrated a significant association of vitamin D insufficiency during pregnancy and increased risk of GDM. 32 A recent randomized controlled trial also found a lower rate of GDM (13% vs 8%) after vitamin D supplementation during early pregnancy, although the difference was not statistically significant due to limited sample size. 34 The observed inverse association of prepregnancy vitamin D intake with GDM risk is biologically supported by the direct and/or indirect effects of vitamin D on insulin secretion and insulin sensitivity. Traditionally, vitamin D is thought to act as a facilitator of intestinal calcium absorption, which, in turn, can normalize glucose intolerance. 35 However, increasing evidence suggests that the effect of vitamin D on β-cells appears to be direct and independent of prevailing plasma calcium concentrations. 6, 36 For example, inadequate vitamin D impairs insulin secretion, 7 and the impairment can be ameliorated by vitamin D supplementation. 37 Moreover, vitamin D receptor and vitamin D-dependent calcium-binding protein are present in human and rat pancreatic islet cells. 38 Vitamin D may regulate pancreatic β-cell function and insulin secretion through the binding of circulating 1,25-dihydroxyvitamin D to β-cell vitamin D receptors. The binding could regulate the balance between extracellular and intracellular calcium pools, which is critical for insulin-mediated intracellular processes in insulinresponsive tissues. 39 In addition, vitamin D can enhance insulin sensitivity by directly activating transcription of the human insulin receptor gene, peroxisome proliferator activator receptor δ, and insulinmediated glucose transport, as well as modulation of cytokine expression and activity. 36, 40 The present study had several strengths. First, the study has a prospective study design with a long duration of follow-up, which establishes the temporal direction of the associations. Second, the questionnaires used to assess diet and lifestyle variables in the present study have been extensively validated. [16] [17] [18] [19] [20] [21] There are several limitations to the present study. First, misclassification of dietary vitamin D intake is possible. However, due to the prospective nature of the study, the misclassification should be non-differential with regard to incident GDM status; therefore, our observed associations may underestimate the true relative risks. Furthermore, the use of cumulative averages of dietary intakes for participants with more than one prepregnancy FFQ reduces random error. Second, the study population consisted mostly of Caucasian American women. Thus, the generalizability of the observed associations may be limited to similar populations. However, the relative homogeneity of the study population reduces potential confounding due to unmeasured socioeconomic variability. Because Black and Hispanic women have a higher prevalence of vitamin D insufficiency than White women do, 5 future studies across races/ethnicities are warranted. Third, the NHSII cohort did not specifically assess diet and lifestyle factors during pregnancy. Therefore, we were unable to assess the association of prepregnancy vitamin D intake with GDM risk, independent of vitamin D intake during pregnancy. Finally, because of observational nature of the present study, a causal relationship between prepregnancy vitamin D intake and GDM risk cannot be inferred.
In conclusion, prepregnancy supplemental vitamin D intake is significantly and inversely associated with risk of GDM. The present study indicates potential benefits of increasing vitamin D intake from supplements in the prevention of GDM in women of reproductive age. Large randomized controlled trials of prepregnancy vitamin D supplementation may be warranted to confirm our findings.
